United States · FDA National Drug Code directory
Montelukast sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 33342-111_a12af8c6-41af-4850-b725-4f8226b35b67
- Product NDC
- 33342-111
- Form
- TABLET, CHEWABLE
- Composition / generic term
- Montelukast sodium
- Labeler
- Macleods Pharmaceuticals Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20150313
- Source listing expiry
- 20261231
Source-listed ingredients
- MONTELUKAST — 5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, CHEWABLE in 1 BOTTLE (33342-111-07) · 33342-111-07
- 90 TABLET, CHEWABLE in 1 BOTTLE (33342-111-10) · 33342-111-10
- 100 TABLET, CHEWABLE in 1 BLISTER PACK (33342-111-12) · 33342-111-12
- 500 TABLET, CHEWABLE in 1 BOTTLE (33342-111-15) · 33342-111-15
- 90 TABLET, CHEWABLE in 1 BLISTER PACK (33342-111-39) · 33342-111-39
- 1000 TABLET, CHEWABLE in 1 BOTTLE (33342-111-44) · 33342-111-44
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →